Anti Pneumococcal Activity of Azithromycin-Eudragit RS100 Nano-Formulations

Advanced Pharmaceutical Bulletin - Iran
doi 10.15171/apb.2016.059
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Maad Rayan Publishing Company

Related search

Desloratadine-Eudragit® RS100 Nanoparticles: Formulation and Characterization

Turkish Journal of Pharmaceutical Sciences
Molecular MedicinePharmaceutical Science
2017English

Novel Curcumin Nano Formulations for Breast Cancer

Multidisciplinary Cancer Investigation
2017English

Reply to Iannetta Et Al., “Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells”

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Prophylactic and Therapeutic Activities of Azithromycin in a Mouse Model of Pneumococcal Pneumonia.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1991English

Intracellular Activity of Azithromycin Against Bacterial Enteric Pathogens.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Treatment of Lobar Pneumonia by Anti-Pneumococcal Serum

BMJ
1932English

Detoxification and Anti-Mycotoxigenic Effect of Ochratoxin a Produced by Penicillium Expansum Species Utilizing Probiotic Pichia Kudriavzevii and Biogenic-Selenium Nano-Formulations

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2019English

Anti-Biogram of Pneumococcal Isolates in a Tertiary Care Hospital

IP International Journal of Medical Microbiology and Tropical Diseases
2018English

Synergistic Activity of Azithromycin and Gamma Interferon in Murine Toxoplasmosis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy